June Lee has served as an independent director of Abivax since July 2023. She has been a venture partner at 5AM Venture Management since July 2022 and was most recently Founder and Chief Executive Officer of Esker Therapeutics until September 2021. She previously served as Executive Vice President and Chief Development Officer of MyoKardia and, before that, on the faculty of the University of California, San Francisco, directing the Catalyst accelerator program, and as a disease area lead in early clinical development at Genentech. She currently serves on the boards of Tenaya Therapeutics, Eledon Pharmaceuticals and GenEdit. She holds a B.A. in chemistry from Johns Hopkins University and an M.D. from the University of California, Davis. She chairs the Remuneration Committee and the Science and Clinical Committee.